From several databases it has been determined that genes DPM1 and 2 are overexpressed, at the mRNA level, in head and neck squamous cell carcinoma, and esophagus, colon, rectum and hepatic cancers (by 1.52- and 2.07-fold for DPM1 and DPM2, respectively, in the latter), while DPM3 is observed overexpressed in esophagus, liver (by 1.67-fold) and breast cancers, as well as in glioblastoma [113]. This evidence concerns the gene DPM2 and liver cancer.